3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Multiple Myeloma
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Burkitt Lymphoma
8
Vomiting
5
Nausea
5
Lymphoma, Mantle-Cell
4
Hodgkin Disease
4
Breast Neoplasms
4
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Leukemia, Biphenotypic, Acute
3
Immunoglobulin Light-chain Amyloidosis
3
Sarcoma
2
Recurrence
2
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmacytoma
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Hairy Cell
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Testicular Neoplasms
1
Interventions
Docetaxel
158
Prednisone
131
Leuprolide
95
bicalutamide
86
enzalutamide
83
Radiotherapy
80
Goserelin
80
Abiraterone Acetate
76
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
54
Magnetic Resonance Spectroscopy
46
Zoledronic Acid
44
gallium 68 PSMA-11
37
Flutamide
34
abiraterone
32
Estramustine
32
radium Ra 223 dichloride
30
apalutamide
27
Surveys and Questionnaires
26
Gonadotropin-Releasing Hormone
26
Androgen Antagonists
25
cabazitaxel
24
Radiosurgery
24
Dutasteride
22
sipuleucel-T
21
Prednisolone
21
Triptorelin Pamoate
20
Paclitaxel
20
luprolide acetate gel depot
19
Radiation
19
Exercise
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Neoplasms
×
dexamethasone acetate
×
Clear all
NCT06136598
2026-03-19
MK-5684-001
Merck Sharp & Dohme LLC
Phase 1
Completed
14 enrolled
NCT00427999
2016-11-21
INV342
Novartis
Phase 2
Completed
67 enrolled
6 charts